YMAB Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-03-12 | TAGLIAFERRI MARY | director | 27,900 | A-Award | A | 27,900 | 16.09 | 448,911.00 |
| 2024-03-12 | TAGLIAFERRI MARY | director | 4,660 | A-Award | A | 4,660 | 0.00 | 0.00 |
| 2024-02-29 | TAGLIAFERRI MARY | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2024-03-05 | Rajah Vignesh | officer: SVP & CHIEF MEDICAL OFFICER | 33,889 | S-Sale | D | 1,711 | 16.53 | 28,283.00 |
| 2024-03-05 | Gad Thomas | director, officer: CHIEF BUSINESS OFFICER | 158,700 | S-Sale | D | 3,900 | 16.44 | 64,116.00 |
| 2024-03-05 | Smith Susan Laura | officer: SVP & CHIEF COMMERCIAL OFFICER | 33,918 | S-Sale | D | 1,682 | 16.55 | 27,837.00 |
| 2024-02-12 | Rossi Michael J | director, officer: PRESIDENT & CEO | 214,200 | A-Award | A | 214,200 | 14.36 | 3,075,912.00 |
| 2024-02-12 | Rossi Michael J | director, officer: PRESIDENT & CEO | 54,000 | A-Award | A | 54,000 | 0.00 | 0.00 |
| 2024-02-12 | Rossi Michael J | director, officer: PRESIDENT & CEO | 35,700 | A-Award | A | 35,700 | 0.00 | 0.00 |
| 2024-01-18 | Rajah Vignesh | officer: SVP & CHIEF MEDICAL OFFICER | 35,700 | A-Award | A | 35,700 | 9.83 | 350,931.00 |
| 2024-01-18 | Rajah Vignesh | officer: SVP & CHIEF MEDICAL OFFICER | 35,600 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2024-01-18 | Smith Susan Laura | officer: SVP & CHIEF COMMERCIAL OFFICER | 35,700 | A-Award | A | 35,700 | 9.83 | 350,931.00 |
| 2024-01-18 | Smith Susan Laura | officer: SVP & CHIEF COMMERCIAL OFFICER | 35,600 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2024-01-18 | Lisby Steen | officer: SVP & CHIEF SCIENTIFIC OFFICER | 35,700 | A-Award | A | 35,700 | 9.83 | 350,931.00 |
| 2024-01-18 | Lisby Steen | officer: SVP & CHIEF SCIENTIFIC OFFICER | 35,600 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2024-01-18 | Wilms Joris | officer: SVP & CHIEF OPERATING OFFICER | 35,700 | A-Award | A | 35,700 | 9.83 | 350,931.00 |
| 2024-01-18 | Wilms Joris | officer: SVP & CHIEF OPERATING OFFICER | 35,600 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2024-01-18 | Lund-Hansen Torben | officer: SVP & CHIEF TECHNICAL OFFICER | 35,700 | A-Award | A | 35,700 | 9.83 | 350,931.00 |
| 2024-01-18 | Lund-Hansen Torben | officer: SVP & CHIEF TECHNICAL OFFICER | 35,600 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2024-01-18 | Gad Thomas | director, officer: CHIEF BUSINESS OFFICER | 162,600 | A-Award | A | 22,100 | 0.00 | 0.00 |
| 2024-01-18 | Gad Thomas | director, officer: CHIEF BUSINESS OFFICER | 132,500 | A-Award | A | 132,500 | 9.83 | 1,302,475.00 |
| 2024-01-18 | Kruse Bo | officer: EVP, CFO, SECRY & TREAS. | 210,877 | A-Award | A | 18,100 | 0.00 | 0.00 |
| 2024-01-18 | Kruse Bo | officer: EVP, CFO, SECRY & TREAS. | 108,900 | A-Award | A | 108,900 | 9.83 | 1,070,487.00 |
| 2023-12-21 | Gad Thomas | director, officer: Chief Business Officer | 140,500 | M-Exempt | A | 50,000 | 2.00 | 100,000.00 |
| 2023-12-21 | Gad Thomas | director, officer: Chief Business Officer | 103,000 | M-Exempt | D | 50,000 | 2.00 | 100,000.00 |
| 2023-12-13 | Gad Thomas | director, officer: Chief Business Officer | 365,032 | S-Sale | D | 50,000 | 6.58 | 329,000.00 |
| 2023-12-14 | Gad Thomas | director, officer: Chief Business Officer | 315,032 | S-Sale | D | 50,000 | 6.83 | 341,500.00 |
| 2023-12-15 | Gad Thomas | director, officer: Chief Business Officer | 265,032 | S-Sale | D | 50,000 | 6.61 | 330,500.00 |
| 2023-12-11 | WG Biotech ApS | director | 4,559,233 | P-Purchase | A | 6,455 | 6.85 | 44,232.00 |
| 2023-12-11 | Wedell-Wedellsborg Johan | director | 4,559,233 | P-Purchase | A | 6,455 | 6.85 | 44,232.00 |
| 2023-12-11 | WG Biotech ApS | director | 4,552,778 | P-Purchase | A | 102,863 | 7.01 | 720,843.00 |
| 2023-12-08 | WG Biotech ApS | director | 4,449,915 | P-Purchase | A | 18,503 | 6.99 | 129,379.00 |
| 2023-12-07 | WG Biotech ApS | director | 4,431,412 | P-Purchase | A | 6,183 | 6.50 | 40,190.00 |
| 2023-12-11 | Wedell-Wedellsborg Johan | director | 4,552,778 | P-Purchase | A | 102,863 | 7.01 | 720,843.00 |
| 2023-12-08 | Wedell-Wedellsborg Johan | director | 4,449,915 | P-Purchase | A | 18,503 | 6.99 | 129,379.00 |
| 2023-12-07 | Wedell-Wedellsborg Johan | director | 4,431,412 | P-Purchase | A | 6,183 | 6.50 | 40,190.00 |
| 2023-11-29 | WG Biotech ApS | director | 4,425,229 | P-Purchase | A | 51,837 | 5.97 | 309,477.00 |
| 2023-11-29 | Wedell-Wedellsborg Johan | director | 4,425,229 | P-Purchase | A | 51,837 | 5.97 | 309,477.00 |
| 2023-11-28 | Wedell-Wedellsborg Johan | director | 4,373,392 | P-Purchase | A | 30,671 | 5.81 | 178,275.00 |
| 2023-11-27 | Wedell-Wedellsborg Johan | director | 4,342,721 | P-Purchase | A | 62,516 | 5.49 | 343,019.00 |
| 2023-11-28 | WG Biotech ApS | director | 4,373,392 | P-Purchase | A | 30,671 | 5.81 | 178,275.00 |
| 2023-11-27 | WG Biotech ApS | director | 4,342,721 | P-Purchase | A | 62,516 | 5.49 | 343,019.00 |
| 2023-11-20 | Gad Thomas | director, officer: Chief Business Officer | 490,032 | S-Sale | D | 75,000 | 5.30 | 397,395.00 |
| 2023-11-21 | Gad Thomas | director, officer: Chief Business Officer | 415,032 | S-Sale | D | 75,000 | 5.31 | 397,988.00 |
| 2023-11-06 | Gad Thomas | director, officer: Chief Business Officer | 75,000 | A-Award | A | 75,000 | 5.75 | 431,250.00 |
| 2023-11-06 | Rossi Michael J | director, officer: President and CEO | 615,240 | A-Award | A | 615,240 | 5.75 | 3,537,630.00 |
| 2023-11-06 | Rossi Michael J | director, officer: President & CEO | 0 | 0 | 0.00 | 0.00 | ||
| 2023-06-08 | Hamill Laura | director | 13,950 | A-Award | A | 13,950 | 8.13 | 113,414.00 |
| 2023-06-08 | Hamill Laura | director | 2,330 | A-Award | A | 2,330 | 0.00 | 0.00 |
| 2023-06-08 | Wedell-Wedellsborg Johan | director | 13,950 | A-Award | A | 13,950 | 8.13 | 113,414.00 |
| 2023-06-08 | Wedell-Wedellsborg Johan | director | 2,330 | A-Award | A | 2,330 | 0.00 | 0.00 |
| 2023-06-08 | Ber Gerard | director | 13,950 | A-Award | A | 13,950 | 8.13 | 113,414.00 |
| 2023-06-08 | Ber Gerard | director | 2,330 | A-Award | A | 2,330 | 0.00 | 0.00 |
| 2023-06-08 | GILL DAVID N | director | 13,950 | A-Award | A | 13,950 | 8.13 | 113,414.00 |
| 2023-06-08 | GILL DAVID N | director | 2,330 | A-Award | A | 2,330 | 0.00 | 0.00 |
| 2023-06-08 | HEALY JAMES | director | 28,108 | A-Award | A | 2,330 | 0.00 | 0.00 |
| 2023-06-08 | HEALY JAMES | director | 13,950 | A-Award | A | 13,950 | 8.13 | 113,414.00 |
| 2023-06-08 | TYAGI ASHU | director | 13,950 | A-Award | A | 13,950 | 8.13 | 113,414.00 |
| 2023-06-08 | TYAGI ASHU | director | 2,330 | A-Award | A | 2,330 | 0.00 | 0.00 |
| 2023-05-15 | Wedell-Wedellsborg Johan | director | 4,280,205 | P-Purchase | A | 101,740 | 9.65 | 981,404.00 |
| 2023-05-15 | WG Biotech ApS | director | 4,280,205 | P-Purchase | A | 101,740 | 9.65 | 981,404.00 |
| 2023-01-26 | Lisby Steen | officer: SVP & CHIEF SCIENTIFIC OFFICER | 32,000 | A-Award | A | 32,000 | 0.00 | 0.00 |
| 2023-01-26 | Lund-Hansen Torben | officer: SVP & CHIEF TECHNICAL OFFICER | 32,000 | A-Award | A | 32,000 | 0.00 | 0.00 |
| 2023-01-26 | Rajah Vignesh | officer: SVP & CHIEF MEDICAL OFFICER | 32,000 | A-Award | A | 32,000 | 0.00 | 0.00 |
| 2023-01-26 | Smith Susan Laura | officer: SVP & CHIEF COMMERCIAL OFFICER | 32,000 | A-Award | A | 32,000 | 0.00 | 0.00 |
| 2023-01-26 | Wilms Joris | officer: SVP & CHIEF OPERATING OFFICER | 32,000 | A-Award | A | 32,000 | 0.00 | 0.00 |
| 2023-01-17 | Rajah Vignesh | officer: SVP & CHIEF MEDICAL OFFICER | 35,700 | A-Award | A | 35,700 | 0.00 | 0.00 |
| 2023-01-17 | Rajah Vignesh | officer: SVP & CHIEF MEDICAL OFFICER | 17,800 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2023-01-17 | Lund-Hansen Torben | officer: SVP & CHIEF TECHNICAL OFFICER | 35,700 | A-Award | A | 35,700 | 0.00 | 0.00 |
| 2023-01-17 | Lund-Hansen Torben | officer: SVP & CHIEF TECHNICAL OFFICER | 17,800 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2023-01-17 | Gad Thomas | officer: See remarks | 243,200 | A-Award | A | 243,200 | 0.00 | 0.00 |
| 2023-01-17 | Gad Thomas | officer: See remarks | 90,500 | A-Award | A | 40,500 | 0.00 | 0.00 |
| 2023-01-17 | Smith Susan Laura | officer: SVP & CHIEF COMMERCIAL OFFICER | 35,700 | A-Award | A | 35,700 | 0.00 | 0.00 |
| 2023-01-17 | Smith Susan Laura | officer: SVP & CHIEF COMMERCIAL OFFICER | 17,800 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2023-01-17 | Lisby Steen | officer: SVP & CHIEF SCIENTIFIC OFFICER | 35,700 | A-Award | A | 35,700 | 0.00 | 0.00 |
| 2023-01-17 | Lisby Steen | officer: SVP & CHIEF SCIENTIFIC OFFICER | 17,800 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2023-01-17 | Wilms Joris | officer: SVP & CHIEF OPERATING OFFICER | 35,700 | A-Award | A | 35,700 | 0.00 | 0.00 |
| 2023-01-17 | Wilms Joris | officer: SVP & CHIEF OPERATING OFFICER | 17,800 | A-Award | A | 17,800 | 0.00 | 0.00 |
| 2023-01-17 | Kruse Bo | officer: EVP, CFO, Secry & Treas. | 192,777 | A-Award | A | 11,700 | 0.00 | 0.00 |
| 2023-01-17 | Kruse Bo | officer: EVP, CFO, Secry & Treas. | 70,100 | A-Award | A | 70,100 | 0.00 | 0.00 |
| 2022-11-15 | Rajah Vignesh | officer: SVP & CMO | 4,266 | P-Purchase | A | 1,195 | 4.92 | 5,884.00 |
| 2022-07-15 | Hamill Laura | director: | 16,000 | A-Award | A | 16,000 | 0.00 | 0.00 |
| 2022-07-15 | Hamill Laura | director | 16,000 | A-Award | A | 16,000 | 16.64 | 266,240.00 |
| 2022-07-15 | Wedell-Wedellsborg Johan | director: | 16,000 | A-Award | A | 16,000 | 0.00 | 0.00 |
| 2022-07-15 | Wedell-Wedellsborg Johan | director | 16,000 | A-Award | A | 16,000 | 16.64 | 266,240.00 |
| 2022-07-15 | HEALY JAMES | director: | 16,000 | A-Award | A | 16,000 | 0.00 | 0.00 |
| 2022-07-15 | HEALY JAMES | director | 16,000 | A-Award | A | 16,000 | 16.64 | 266,240.00 |
| 2022-07-15 | Ber Gerard | director: | 16,000 | A-Award | A | 16,000 | 0.00 | 0.00 |
| 2022-07-15 | Ber Gerard | director | 16,000 | A-Award | A | 16,000 | 16.64 | 266,240.00 |
| 2022-07-15 | GILL DAVID N | director: | 16,000 | A-Award | A | 16,000 | 0.00 | 0.00 |
| 2022-07-15 | GILL DAVID N | director | 16,000 | A-Award | A | 16,000 | 16.64 | 266,240.00 |
| 2022-07-15 | TYAGI ASHU | director: | 16,000 | A-Award | A | 16,000 | 0.00 | 0.00 |
| 2022-07-15 | TYAGI ASHU | director | 16,000 | A-Award | A | 16,000 | 16.64 | 266,240.00 |
| 2022-05-18 | Gad Thomas | officer: See remarks | 60,000 | A-Award | A | 60,000 | 0.00 | 0.00 |
| 2022-04-26 | Rajah Vignesh | officer: SVP & CMO | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-04-26 | Lund-Hansen Torben | officer: SVP & CTO | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-04-26 | Lund-Hansen Torben | officer: SVP & CTO | 20,000 | A-Award | A | 20,000 | 9.51 | 190,200.00 |
| 2022-04-26 | Smith Susan Laura | officer: SVP & CCO | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-04-26 | Lisby Steen | officer: SVP & CSO | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2022-04-26 | Wilms Joris | officer: SVP & COO | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
